Chen, W;
(2025)
Fragment-based drug discovery for transthyretin kinetic stabilisers using a novel capillary zone electrophoresis method.
PLOS One
, 20
, Article e0323816. 10.1371/journal.pone.0323816.
Preview |
PDF
Fragment-based drug discovery for transthyretin kinetic stabilisers using a novel capillary zone electrophoresis method.pdf - Published Version Download (2MB) | Preview |
Abstract
A Capillary Zone Electrophoresis (CZE) fragment screening methodology was developed and applied to the human plasma protein Transthyretin (TTR), normally soluble, but could misfold and aggregate, causing amyloidosis. Termed Free Probe Peak Height Restoration (FPPHR), it monitors changes in the level of free ligand known to bind TTR (the Probe Ligand) in the presence of competing fragments. 129 fragments were screened, 12 of the 16 initial hits (12.4% hit rate) were co-crystallised with TTR, 11 were found at the binding site (92% confirmation rate). Subsequent analogue screens have identified a novel TTR-binding scaffold 4-(3H-pyrazol-4-yl) quinoline and its derived compounds were further studied by crystallography, circular dichroism (CD), isothermal titration calorimetry (ITC) and radiolabelled <sup>125</sup>I-Thyroxine displacement assay in neat plasma. Two lead molecules had similar ITC K<inf>d</inf> and <sup>125</sup>I-Thyroxine displacement IC<inf>50</inf> values to that of Tafamidis, adding another potential pipeline for transthyretin amyloidosis. The methodology is reproducible, procedurally simple, automatable, label-free without target immobilisation, non-fluorescence based and site-specific with low false positive rate, which could be applicable to fragment screening of many drug targets.
Type: | Article |
---|---|
Title: | Fragment-based drug discovery for transthyretin kinetic stabilisers using a novel capillary zone electrophoresis method |
Location: | United States |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1371/journal.pone.0323816 |
Publisher version: | https://doi.org/10.1371/journal.pone.0323816 |
Language: | English |
Additional information: | This work is licensed under a Creative Commons License. The images or other third-party material in this article are included in the Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
Keywords: | Prealbumin, Humans, Electrophoresis, Capillary, Drug Discovery, Kinetics, Benzoxazoles, Quinolines, Protein Binding, Binding Sites, Amyloid Neuropathies, Familial |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharma and Bio Chemistry |
URI: | https://discovery.ucl.ac.uk/id/eprint/10209762 |
Archive Staff Only
![]() |
View Item |